688065 凯赛生物
已收盘 09-27 15:00:00
资讯
新帖
简况
9月27日凯赛生物涨6.88%，科创板博时基金重仓该股
证券之星 · 09-27 16:36
9月27日凯赛生物涨6.88%，科创板博时基金重仓该股
凯赛生物涨6.88%，华安证券一个月前给出“买入”评级
证券之星 · 09-27 16:36
凯赛生物涨6.88%，华安证券一个月前给出“买入”评级
凯赛生物创1个月新高 2024河南与跨国公司合作交流会举行
智选洞察 · 09-27 09:57
凯赛生物创1个月新高 2024河南与跨国公司合作交流会举行
凯赛生物创1个月新高 跨国公司合作交流会助推河南生物医药产业发展
智选洞察 · 09-26 13:53
凯赛生物创1个月新高 跨国公司合作交流会助推河南生物医药产业发展
9月24日凯赛生物现1笔折价26.64%的大宗交易 合计成交787.2万元
证券之星 · 09-24
9月24日凯赛生物现1笔折价26.64%的大宗交易 合计成交787.2万元
9月24日凯赛生物涨9.05%，科创板博时基金重仓该股
证券之星 · 09-24
9月24日凯赛生物涨9.05%，科创板博时基金重仓该股
凯赛生物涨9.05%，华安证券一个月前给出“买入”评级
证券之星 · 09-24
凯赛生物涨9.05%，华安证券一个月前给出“买入”评级
凯赛生物大幅上涨 获主力净流入146万元
智选洞察 · 09-24
凯赛生物大幅上涨 获主力净流入146万元
9月23日凯赛生物现1笔折价19.21%的大宗交易 合计成交1054.89万元
证券之星 · 09-23
9月23日凯赛生物现1笔折价19.21%的大宗交易 合计成交1054.89万元
凯赛生物09月19日遭主力抛售295万元 环比增加125.19%
市场透视 · 09-19
凯赛生物09月19日遭主力抛售295万元 环比增加125.19%
凯赛生物： 公司遵守信息披露规则，对应披露的信息进行及时披露
证券之星 · 09-18
凯赛生物： 公司遵守信息披露规则，对应披露的信息进行及时披露
凯赛生物：新能源是公司生物基新材料的重要应用领域之一
每日经济新闻 · 09-18
凯赛生物：新能源是公司生物基新材料的重要应用领域之一
凯赛生物获得发明专利授权：“用于发酵生产1,5-戊二胺的重组DNA、菌株及其用途”
证券之星 · 09-18
凯赛生物获得发明专利授权：“用于发酵生产1,5-戊二胺的重组DNA、菌株及其用途”
凯赛生物09月13日主力资金流入265万元 连续3日加仓
市场透视 · 09-13
凯赛生物09月13日主力资金流入265万元 连续3日加仓
凯赛生物09月10日遭主力抛售410万元 环比增加2057.89%
市场透视 · 09-10
凯赛生物09月10日遭主力抛售410万元 环比增加2057.89%
凯赛生物09月06日主力资金流出74万元 连续3日减仓
市场透视 · 09-06
凯赛生物09月06日主力资金流出74万元 连续3日减仓
凯赛生物09月05日遭主力抛售149万元 环比增加1141.67%
市场透视 · 09-05
凯赛生物09月05日遭主力抛售149万元 环比增加1141.67%
合成生物概念盘中拉升，金禾实业涨6.00%
市场透视 · 08-30
合成生物概念盘中拉升，金禾实业涨6.00%
【广发基金刘格菘建仓法拉电子、菲利华，称“下半年资本市场预计会好于上半年”】金十数据8月29日讯，广发基金副总经理刘格菘管理的广发小盘成长混合基金2024年中报率先披露。
美港电讯 · 08-29
【广发基金刘格菘建仓法拉电子、菲利华，称“下半年资本市场预计会好于上半年”】金十数据8月29日讯，广发基金副总经理刘格菘管理的广发小盘成长混合基金2024年中报率先披露。
凯赛生物等66亿定增落槌，资本运作出现央企身影
蓝鲸财经 · 08-29
凯赛生物等66亿定增落槌，资本运作出现央企身影
公司概况
公司名称：
上海凯赛生物技术股份有限公司
所属行业：
化学纤维制造业
上市日期：
2020-08-12
主营业务：
上海凯赛生物技术股份有限公司从事新型生物基材料的研发、生产及销售。公司目前主要产品为生物法长链二元酸系列产品、生物基聚酰胺及单体产品等。公司重视打造技术竞争力，坚持走自主创新的发展道路，截至报告期末公司拥有318项发明专利在内的406项专利，获得国际纺织制造商联合会（ITMF）颁发的“《可持续与创新奖》（SUSTAINABILITY&INNOVATION）”，被认定为“国家企业技术中心”、“国家级第三批专精特新‘小巨人’企业”、“国家知识产权局优势企业”。
发行价格：
133.45
{"stockData":{"symbol":"688065","market":"SH","secType":"STK","nameCN":"凯赛生物","latestPrice":40.7,"timestamp":1727420400000,"preClose":38.08,"halted":0,"volume":2296252,"delay":0,"floatShares":583000000,"shares":583000000,"eps":0.6379,"marketStatus":"已收盘","marketStatusCode":5,"change":2.62,"latestTime":"09-27 15:00:00","open":38.95,"high":41,"low":38.56,"amount":91264800,"amplitude":0.0641,"askPrice":40.7,"askSize":158,"bidPrice":40.69,"bidSize":9,"shortable":0,"etf":0,"ttmEps":0.6379,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1727659800000},"adr":0,"adjPreClose":38.08,"symbolType":"stock_kcb","openAndCloseTimeList":[[1727400600000,1727407800000],[1727413200000,1727420400000]],"highLimit":41.89,"lowLimit":34.27,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":583378039,"pbRate":2.1,"roa":"--","roe":"2.19%","epsLYR":0.63,"committee":-0.341176,"marketValue":23743000000,"floatMarketCap":23743000000,"peRate":63.803104,"changeRate":0.0688,"turnoverRate":0.0039,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-09-30。","afterMarket":{"amount":0,"volume":0,"close":40.7,"buyVolume":0,"sellVolume":0,"time":1727422437153,"indexStatus":"已收盘 09-27 15:30:00","preClose":38.08}},"requestUrl":"/m/hq/s/688065/wiki","defaultTab":"wiki","newsList":[{"id":"2470776480","title":"9月27日凯赛生物涨6.88%，科创板博时基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470776480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470776480?lang=zh_cn&edition=full","pubTime":"2024-09-27 16:36","pubTimestamp":1727426198,"startTime":"0","endTime":"0","summary":"证券之星消息，9月27日凯赛生物涨6.88%，收盘报40.7元，换手率0.39%，成交量2.3万手，成交额9126.48万元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为科创板博时。科创板博时目前规模为10.14亿元，最新净值0.5522，较上一交易日上涨3.86%，近一年下跌26.8%。科创板博时的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092700024747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159982","BK0208","688065"],"gpt_icon":0},{"id":"2470776173","title":"凯赛生物涨6.88%，华安证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2470776173","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470776173?lang=zh_cn&edition=full","pubTime":"2024-09-27 16:36","pubTimestamp":1727426188,"startTime":"0","endTime":"0","summary":"今日凯赛生物涨6.88%，收盘报40.7元。2024年8月19日，华安证券研究员王强峰,刘天其发布了对凯赛生物的研报《Q2业绩环比大幅改善，二元酸景气度持续回暖》，该研报对凯赛生物给出“买入”评级。维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为56.98%。凯赛生物个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092700024741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","600909"],"gpt_icon":0},{"id":"2470488377","title":"凯赛生物创1个月新高 2024河南与跨国公司合作交流会举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2470488377","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470488377?lang=zh_cn&edition=full","pubTime":"2024-09-27 09:57","pubTimestamp":1727402221,"startTime":"0","endTime":"0","summary":"09月27日，凯赛生物股价大幅上涨，截至09点57分，凯赛生物上涨5.02%，报39.99元/股，创近1个月新高，成交4603万元，换手率0.20%。消息解读9月25日，2024河南与跨国公司合作交流会现代医药产业圆桌对接会在郑州举行。此次会议旨在深化河南与跨国公司在生物医药产业领域的务实合作，通过广泛深入交流，实现政企双向关注，推动与会企业与河南达成一批合作意向，助推河南生物医药产业高质量发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927095839ab6651bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927095839ab6651bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2470327960","title":"凯赛生物创1个月新高 跨国公司合作交流会助推河南生物医药产业发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2470327960","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470327960?lang=zh_cn&edition=full","pubTime":"2024-09-26 13:53","pubTimestamp":1727330035,"startTime":"0","endTime":"0","summary":"消息解读2024年9月25日，河南与跨国公司合作交流会现代医药产业圆桌对接会在郑州举行，旨在深化河南与跨国公司在生物医药产业领域的务实合作，通过广泛深入交流，实现政企双向关注，推动与会企业与河南达成一批合作意向，助推河南生物医药产业高质量发展。出席当日对接会的中国美国商会会长何迈可表示，河南为外国公司提供了良好的商业环境，创造了巨大的投资潜力，中原医学科学城为医疗和生物制药行业的发展树立了良好榜样。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926135422ab6612ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926135422ab6612ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065","399441","161726"],"gpt_icon":0},{"id":"2469450917","title":"9月24日凯赛生物现1笔折价26.64%的大宗交易 合计成交787.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469450917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469450917?lang=zh_cn&edition=full","pubTime":"2024-09-24 17:29","pubTimestamp":1727170141,"startTime":"0","endTime":"0","summary":"证券之星消息，9月24日凯赛生物发生大宗交易，交易数据如下：大宗交易成交价格26.24元，相对当日收盘价折价26.64%，成交30万股，成交金额787.2万元，买方营业部为中信建投证券股份有限公司北京海淀分公司，卖方营业部为长城证券股份有限公司重庆新南路证券营业部。近三个月该股共发生4笔大宗交易，合计成交1.46万手，折价成交4笔。截至2024年9月24日收盘，凯赛生物报收于35.77元，上涨9.05%，换手率0.45%，成交量2.6万手，成交额8999.63万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092400027013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2469545167","title":"9月24日凯赛生物涨9.05%，科创板博时基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2469545167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469545167?lang=zh_cn&edition=full","pubTime":"2024-09-24 16:36","pubTimestamp":1727166981,"startTime":"0","endTime":"0","summary":"证券之星消息，9月24日凯赛生物涨9.05%，收盘报35.77元，换手率0.45%，成交量2.6万手，成交额8999.63万元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为科创板博时。科创板博时目前规模为10.14亿元，最新净值0.512，较上一交易日下跌0.25%，近一年下跌31.66%。科创板博时的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092400024463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208","159982"],"gpt_icon":0},{"id":"2469451371","title":"凯赛生物涨9.05%，华安证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2469451371","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469451371?lang=zh_cn&edition=full","pubTime":"2024-09-24 16:36","pubTimestamp":1727166975,"startTime":"0","endTime":"0","summary":"今日凯赛生物涨9.05%，收盘报35.77元。2024年8月19日，华安证券研究员王强峰,刘天其发布了对凯赛生物的研报《Q2业绩环比大幅改善，二元酸景气度持续回暖》，该研报对凯赛生物给出“买入”评级。对应PE分别为40、30、23倍。维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中信建投的卢昊。凯赛生物个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092400024461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","688065"],"gpt_icon":0},{"id":"2469489217","title":"凯赛生物大幅上涨 获主力净流入146万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469489217","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469489217?lang=zh_cn&edition=full","pubTime":"2024-09-24 11:11","pubTimestamp":1727147485,"startTime":"0","endTime":"0","summary":"09月24日，凯赛生物股价大幅上涨，截至11点11分，凯赛生物上涨5.15%，报34.49元/股，成交3669万元，换手率0.19%，振幅4.15%。资金动向截止发稿，凯赛生物获得主力净流入146万元，其中超大单流入48万元，大单流入97万元。最新财报显示，今年中报，凯赛生物实现营业收入14.44亿元，同比增长40.16%，净利润为2.47亿元，同比增长2.31%，基本每股收益为0.42元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924111132ab6580d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924111132ab6580d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2469981371","title":"9月23日凯赛生物现1笔折价19.21%的大宗交易 合计成交1054.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469981371","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469981371?lang=zh_cn&edition=full","pubTime":"2024-09-23 17:20","pubTimestamp":1727083245,"startTime":"0","endTime":"0","summary":"证券之星消息，9月23日凯赛生物发生大宗交易，交易数据如下：大宗交易成交价格26.5元，相对当日收盘价折价19.21%，成交39.81万股，成交金额1054.89万元，买方营业部为中信证券股份有限公司杭州崇仁路证券营业部，卖方营业部为长城证券股份有限公司重庆新南路证券营业部。近三个月该股共发生3笔大宗交易，合计成交1.16万手，折价成交3笔。截至2024年9月23日收盘，凯赛生物报收于32.8元，下跌0.61%，换手率0.15%，成交量8607.0手，成交额2848.16万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092300021731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2468541823","title":"凯赛生物09月19日遭主力抛售295万元 环比增加125.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468541823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468541823?lang=zh_cn&edition=full","pubTime":"2024-09-19 15:19","pubTimestamp":1726730352,"startTime":"0","endTime":"0","summary":"09月19日, 凯赛生物股价涨2.69%，报收33.96元，成交金额5726万元，换手率0.29%，振幅5.08%，量比1.34。凯赛生物今日主力资金净流出295万元，上一交易日主力净流出131万元，今日环比增加125.19%。|09月19日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|宏盛华源|6.96%|#|岭南股份|4.65%|#|旗天科技|4.28%|#|国中水务|3.47%|#|古鳌科技|2.78%|#|品渥食品|2.62%|#|深华发Ａ|2.51%|#|老百姓|2.35%|#|襄阳轴承|2.30%|#|高斯贝尔|2.21%|凯赛生物所在的化学制品行业，今日主力净流入1.09亿元，行业排名38/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409191532199f072c8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409191532199f072c8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2468709243","title":"凯赛生物：\n公司遵守信息披露规则，对应披露的信息进行及时披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2468709243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468709243?lang=zh_cn&edition=full","pubTime":"2024-09-18 17:00","pubTimestamp":1726650050,"startTime":"0","endTime":"0","summary":"目前公司和合作伙伴共同进行产品的试制和验证。这是真的不看好公司前景吗凯赛生物董秘：尊敬的投资者您好，公司遵守信息披露规则，对应披露的信息进行及时披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800024030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2468137421","title":"凯赛生物：新能源是公司生物基新材料的重要应用领域之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2468137421","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468137421?lang=zh_cn&edition=full","pubTime":"2024-09-18 16:13","pubTimestamp":1726647207,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：有消息说凯赛生物正在和宁德时代进行战略合作，基于公司的生物基聚酰胺开发新型电池壳材料、电池包封装材料、储能系统液冷管路材料、新能源车热管理管路材料，请问这消息属实吗，能不能透露一下这些项目的具体进展以及对公司未来业绩的影响？凯赛生物（688065.SH）9月18日在投资者互动平台表示，新能源是公司生物基新材料的重要应用领域之一，公司开发的生物基聚酰胺复合材料、生物基长链聚酰胺等产品可应用于动力电池、储能、汽车热管理零部件等。目前公司和合作伙伴共同进行产品的试制和验证。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409181613599f048b6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409181613599f048b6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208","160640","000941.SH","159875","399941","159703"],"gpt_icon":0},{"id":"2468393931","title":"凯赛生物获得发明专利授权：“用于发酵生产1,5-戊二胺的重组DNA、菌株及其用途”","url":"https://stock-news.laohu8.com/highlight/detail?id=2468393931","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468393931?lang=zh_cn&edition=full","pubTime":"2024-09-18 02:15","pubTimestamp":1726596931,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示凯赛生物新获得一项发明专利授权，专利名为“用于发酵生产1,5-戊二胺的重组DNA、菌株及其用途”，专利申请号为CN202110402224.5，授权日为2024年9月17日。专利摘要：本发明提供用于发酵生产1,5戊二胺的重组DNA、菌株及其用途。今年以来凯赛生物新获得专利授权54个，较去年同期增加了5.88%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800001057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2467716429","title":"凯赛生物09月13日主力资金流入265万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2467716429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467716429?lang=zh_cn&edition=full","pubTime":"2024-09-13 15:18","pubTimestamp":1726211883,"startTime":"0","endTime":"0","summary":"09月13日, 凯赛生物股价涨0.47%，报收34.08元，成交金额5013万元，换手率0.25%，振幅2.54%，量比1.38。凯赛生物今日主力资金净流入265万元，连续3日净流入，上一交易日主力净流入156万元，今日环比增加69.87%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为27.27%，平均涨幅为1.27%。该股近5个交易日下跌0.58%，主力资金累计净流入134万元；近20日主力资金累计净流出134万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091315250095623dc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091315250095623dc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2466029491","title":"凯赛生物09月10日遭主力抛售410万元 环比增加2057.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2466029491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466029491?lang=zh_cn&edition=full","pubTime":"2024-09-10 15:18","pubTimestamp":1725952691,"startTime":"0","endTime":"0","summary":"09月10日, 凯赛生物股价跌0.76%，报收33.84元，成交金额3703万元，换手率0.19%，振幅2.93%，量比1.17。凯赛生物今日主力资金净流出410万元，连续5日净流出，上一交易日主力净流出19万元，今日环比增加2057.89%。该股近5个交易日下跌3.48%，主力资金累计净流出661万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出703万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409101526479ef1435a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409101526479ef1435a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2465654767","title":"凯赛生物09月06日主力资金流出74万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2465654767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465654767?lang=zh_cn&edition=full","pubTime":"2024-09-06 15:19","pubTimestamp":1725607154,"startTime":"0","endTime":"0","summary":"09月06日, 凯赛生物股价跌2.78%，报收34.28元，成交金额3055万元，换手率0.15%，振幅3.94%，量比0.67。凯赛生物今日主力资金净流出74万元，连续3日净流出，上一交易日主力净流出149万元，今日环比减少50.34%。该股近5个交易日下跌5.02%，主力资金累计净流出16万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出630万元，其中净流出天数为16日。凯赛生物所在的化学制品行业，今日主力净流出4388万元，行业排名45/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409061535319ee4d8cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409061535319ee4d8cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2465351115","title":"凯赛生物09月05日遭主力抛售149万元 环比增加1141.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2465351115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465351115?lang=zh_cn&edition=full","pubTime":"2024-09-05 15:17","pubTimestamp":1725520672,"startTime":"0","endTime":"0","summary":"09月05日, 凯赛生物股价涨0.57%，报收35.26元，成交金额3329万元，换手率0.16%，振幅1.68%，量比0.71。凯赛生物今日主力资金净流出149万元，上一交易日主力净流出12万元，今日环比增加1141.67%。该股近5个交易日上涨0.77%，主力资金累计净流入1179万元；近20日主力资金累计净流出704万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409051523049ee2075f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409051523049ee2075f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2463283452","title":"合成生物概念盘中拉升，金禾实业涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463283452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463283452?lang=zh_cn&edition=full","pubTime":"2024-08-30 10:04","pubTimestamp":1724983477,"startTime":"0","endTime":"0","summary":"08月30日，合成生物概念盘中拉升，截至10点04分，合成生物概念整体指数上涨1.02%，报829.240点。从个股上来看，该概念的成分股中，金禾实业涨6.00%，天宇股份、凯赛生物、华恒生物涨幅居前。从资金上来看，截止发稿，合成生物概念主力净流入为-6293.15万，其中凯赛生物受到资金热捧，主力净流入504.70万；拉长时间线来看，该板块近20日主力资金净流入-32.39亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024083010043794201838&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024083010043794201838&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002597","BK0186","BK0175","BK0201","688065","BK0197","BK0226","BK0208"],"gpt_icon":0},{"id":"2463281281","title":"【广发基金刘格菘建仓法拉电子、菲利华，称“下半年资本市场预计会好于上半年”】金十数据8月29日讯，广发基金副总经理刘格菘管理的广发小盘成长混合基金2024年中报率先披露。","url":"https://stock-news.laohu8.com/highlight/detail?id=2463281281","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463281281?lang=zh_cn&edition=full","pubTime":"2024-08-29 17:38","pubTimestamp":1724924280,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0188","SG9999001051.SGD","SGXZ49509284.SGD","600563","BK0014","300782","SG9999002950.SGD","688390","SGXZ81163826.USD","BK0224","688065","LU2580892862.HKD","688599","BK0028","SG9999001069.SGD","162703","BK0208","LU1820825898.SGD","BK0003","BK0214","LU2580892789.USD","SG9999001093.SGD","LU1146622755.USD","300395","BK0235"],"gpt_icon":0},{"id":"2463421267","title":"凯赛生物等66亿定增落槌，资本运作出现央企身影","url":"https://stock-news.laohu8.com/highlight/detail?id=2463421267","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463421267?lang=zh_cn&edition=full","pubTime":"2024-08-29 10:05","pubTimestamp":1724897125,"startTime":"0","endTime":"0","summary":"业绩表现上，伴随合成生物学产品的市场回暖，公司相关指标出现上涨。7月底，公司公开定增预案的二次修订稿。2023年，公司发布定增计划，最高募资66亿元，实控人刘修才家族以所持部分股票出资，招商局的出资方式为现金。2020年，凯赛生物成功上市，如今再度迎来关键时刻，也引发监管层的问询。截至今年上半年，公司在建工程56.4亿元，占总资产的30.79%；固定资产超40亿元，占总资产的21.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408291006109f637c94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408291006109f637c94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-12","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路1690号5幢4楼","stockEarnings":[{"period":"1week","weight":0.1213},{"period":"1month","weight":0.1121},{"period":"3month","weight":-0.157},{"period":"6month","weight":-0.1331},{"period":"1year","weight":-0.3085},{"period":"ytd","weight":-0.3041}],"companyName":"上海凯赛生物技术股份有限公司","boardCode":"AI0028","perCapita":"59833股","boardName":"化学纤维制造业","registeredCapital":"58337万元","compareEarnings":[{"period":"1week","weight":0.0968},{"period":"1month","weight":0.0534},{"period":"3month","weight":0.0113},{"period":"6month","weight":-0.0132},{"period":"1year","weight":-0.0342},{"period":"ytd","weight":0.0087}],"survey":" 上海凯赛生物技术股份有限公司从事新型生物基材料的研发、生产及销售。公司目前主要产品为生物法长链二元酸系列产品、生物基聚酰胺及单体产品等。公司重视打造技术竞争力，坚持走自主创新的发展道路，截至报告期末公司拥有318项发明专利在内的406项专利，获得国际纺织制造商联合会（ITMF）颁发的“《可持续与创新奖》（SUSTAINABILITY&INNOVATION）”，被认定为“国家企业技术中心”、“国家级第三批专精特新‘小巨人’企业”、“国家知识产权局优势企业”。","serverTime":1727453891233,"listedPrice":133.45,"stockholders":"9750人(较上一季度增加5.18%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯赛生物,688065,凯赛生物股票,凯赛生物股票老虎,凯赛生物股票老虎国际,凯赛生物行情,凯赛生物股票行情,凯赛生物股价,凯赛生物股市,凯赛生物股票价格,凯赛生物股票交易,凯赛生物股票购买,凯赛生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}